Literature DB >> 29622890

Incidental Discovery of Anti-IH in a Patient Planned for Caesarean Section and it's Repercussions.

Lin-Nan Shao1, Wen-Qian Song1, Ni Wang1, Wei-Jian Yu1, Shi-Hang Zhou1.   

Abstract

Entities:  

Keywords:  Anti-IH; Compound antibody; Pan-agglutination; Pregnant woman

Year:  2017        PMID： 29622890      PMCID： PMC5884999          DOI： 10.1007/s12288-017-0891-z

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  5 in total

1.  Hemolytic transfusion reaction due to anti-IH.

Authors:  Mehraboon S Irani; Cheryl Richards
Journal:  Transfusion       Date:  2011-06-09       Impact factor: 3.157

2.  An acute hemolytic transfusion reaction due to anti-IH in a patient with sickle cell disease.

Authors:  S A Campbell; R S Shirey; K E King; P M Ness
Journal:  Transfusion       Date:  2000-07       Impact factor: 3.157

3.  Life-threatening delayed hyperhemolytic transfusion reaction in a patient with sickle cell disease: effective treatment with eculizumab followed by rituximab.

Authors:  Mark Boonyasampant; Ilene C Weitz; Brian Kay; Chaiyaporn Boonchalermvichian; Howard A Liebman; Ira A Shulman
Journal:  Transfusion       Date:  2015-05-18       Impact factor: 3.157

4.  Acute hemolysis of transfused A2 red cells by an auto-HI antibody.

Authors:  Kamran Darabi; Robert S Makar
Journal:  Transfusion       Date:  2008-05       Impact factor: 3.157

5.  Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients.

Authors:  Clara Ibanez; Anoosha Habibi; Armand Mekontso-Dessap; Philippe Chadebech; Btissam Chami; Philippe Bierling; Frédéric Galactéros; Claire Rieux; Joëlle Nataf; Pablo Bartolucci; Thierry Peyrard; France Pirenne
Journal:  Transfusion       Date:  2016-05-03       Impact factor: 3.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.